{
    "deliberation_results": {
        "EpidemicModelingSpecialist (SEIRCompartmentalModels)": {
            "time_to_resolution": "Approximately 8 weeks (until January 1, 2026)",
            "perspective_relevance": "As an EpidemicModelingSpecialist with expertise in SEIR Compartmental Models, my approach is to quantitatively analyze the mechanisms underlying infectious disease spread. This includes understanding rates of zoonotic spillover, potential for sustained human-to-human transmission, surveillance/reporting dynamics, and the effect of population structure and contact patterns. My perspective allows me to parse whether current H5N1/H5 spillover patterns could, even in a worst-case scenario, plausibly produce >10,000 CDC-reported confirmed/probable human cases within the next two months.",
            "status_quo": "As of December 11, 2024, the CDC had reported 58 human cases of H5 in the US for 2024, and approximately 70 cases are reported as of mid-2025. All cases to date have been sporadic, primarily occupational, with no sustained human-to-human transmission. The status quo is that human cases are rare, and the CDC continues to report only small, direct-exposure outbreaks.",
            "perspective_derived_factors": [
                {
                    "factor": "Absence of sustained human-to-human transmission",
                    "effect": "Strongly decreases probability. Without a significant change in transmission dynamics, SEIR models predict only sporadic, direct-exposure cases, not exponential growth required for 10,000+ cases."
                },
                {
                    "factor": "Case definition and reporting limitations",
                    "effect": "Decreases probability. The question counts only confirmed or probable cases reported by CDC before Jan 1, 2026. Even with underdiagnosis, the reporting infrastructure and focus on symptomatic/occupational contacts sharply limits numbers."
                },
                {
                    "factor": "Current growth rate and base rate of human cases",
                    "effect": "Strongly decreases probability. The US has seen ~70 cases in more than a year since the first dairy cow outbreaks, for an average of 4-6 cases/month. There is no sign of exponential growth."
                },
                {
                    "factor": "Potential for viral mutation (e.g., Q226L in HA) enabling efficient human transmission",
                    "effect": "Slightly increases probability, but only marginally within the forecast window. While a single mutation could raise pandemic risk, surveillance and sequencing to date have not detected such adaptation in US outbreaks. The probability of such a shift, followed by explosive spread and detection/reporting of >10,000 cases in under 2 months, is extremely low."
                },
                {
                    "factor": "Surveillance sensitivity and federal government shutdown",
                    "effect": "Decreases probability. While a shutdown could reduce detection/reporting, it is more likely to delay or undercount cases rather than inflate reported case numbers. It is highly unlikely that it would result in a sudden surge in reporting that pushes the count over 10,000."
                },
                {
                    "factor": "Asymptomatic or mild infections",
                    "effect": "Neutral to slightly decreases probability. While recent reviews show some asymptomatic infections and limited person-to-person spread, the CDC's reporting is focused on confirmed/probable cases, not estimates or seroprevalence. The presence of undetected infections does not translate into a spike in CDC-reported cases."
                }
            ],
            "no_scenario": "H5N1 continues to infect poultry, wild birds, dairy cattle, and occasionally spills over to humans with direct animal contact. Cases remain sporadic, occupational, and mild or moderate. There are no clusters indicating efficient human-to-human transmission. Surveillance, even if hampered by the shutdown, does not report more than a handful of new cases, and the total reported by the CDC remains well below 10,000 by January 1, 2026.",
            "yes_scenario": "A sudden and dramatic change occurs: H5N1 acquires a mutation (e.g., Q226L HA) leading to efficient human-to-human transmission. This results in a rapidly growing epidemic in late 2025, with thousands of symptomatic cases presenting to healthcare and being tested/reported as confirmed/probable by the CDC, with the total surpassing 10,000 before January 1, 2026. Alternatively, a major reporting artifact or redefinition occurs, causing the CDC to suddenly report a backlog or new category of cases that pushes the count over 10,000.",
            "final_reasoning": "The base rate for zoonotic avian influenza spillover, even during major animal outbreaks, is extremely low\u2014typically tens or low hundreds of cases worldwide per year, with the US seeing ~70 total in 2024-2025. SEIR modeling indicates that, absent a sudden, clear shift to efficient human-to-human transmission (for which there is no evidence), there is simply not enough time or transmission potential to reach 10,000 confirmed/probable CDC-reported human cases in under 2 months. The only plausible Yes scenario would require a genomic shift, followed by explosive epidemic growth, and immediate, large-scale detection and reporting\u2014an event with vanishingly low probability given current surveillance and epidemiological data. The government shutdown may impede data collection, but it cannot create cases, and would more likely reduce rather than increase reported counts. While ongoing animal outbreaks and rare asymptomatic human infections are concerning, they do not substantially increase the probability of a sudden, massive wave of CDC-reported cases. Therefore, the probability is extremely low\u2014much closer to 0% than to any meaningful risk.",
            "final_probability": 1
        },
        "EpidemicModelingSpecialist (EventBasedSurveillance)": {
            "time_to_resolution": "Approximately 1 year and 2 months (until December 31, 2025)",
            "perspective_relevance": "As an EpidemicModelingSpecialist with EventBasedSurveillance expertise, my approach centers on integrating epidemiological base rates, surveillance quality, zoonotic spillover risk, viral genetics, and public health infrastructure capacity to assess outbreak trajectories. I am attuned to both the statistical realities of case accumulation and the impact of surveillance/reporting disruptions (e.g., CDC shutdown) on official case counts, as well as the mechanisms by which zoonotic pathogens cross species barriers and acquire pandemic potential.",
            "status_quo": "As of December 2024, only 58 CDC-reported US human H5 cases occurred year-to-date (2024), with 70 cumulative cases by May 2025. All cases have so far been linked to direct animal exposure (poultry or cattle), with no confirmed sustained human-to-human transmission. CDC and WHO consider public risk low, and historical case counts for zoonotic influenza in the US are extremely low relative to the 10,000 threshold. If nothing changes, the total by end of 2025 will remain orders of magnitude below 10,000.",
            "perspective_derived_factors": [
                {
                    "factor": "Base Rate of Human H5 Infections",
                    "effect": "Strongly decreases probability. The US has reported only 70 cumulative human cases in nearly two years, with growth driven by occupational exposure and no evidence of exponential increase. Achieving 10,000 cases in 13 months would require a >100-fold increase in monthly incidence\u2014unprecedented in the absence of major changes in transmissibility."
                },
                {
                    "factor": "Viral Genetic Barriers and Mutation Risk",
                    "effect": "Slightly increases probability. Recent research highlights that a single HA mutation could enable human receptor binding, raising the theoretical risk of a sudden jump in human-to-human transmission. But as of now, this mutation has not been documented in circulating US strains, and no epidemiological evidence shows efficient human transmission."
                },
                {
                    "factor": "Current Zoonotic Reservoirs and Mammalian Adaptation",
                    "effect": "Marginally increases probability. The virus's spread among cattle and other mammals creates ecological conditions for adaptation. However, most spillovers remain linked to animal contact, and no clear evidence exists for sustained adaptation to humans in the US context."
                },
                {
                    "factor": "Public Health Surveillance and Reporting Disruptions",
                    "effect": "Marginally decreases probability. CDC reporting has been hampered by the federal shutdown, reducing the likelihood of even detected cases being reported promptly. If the reporting system remains impaired, large numbers of mild/asymptomatic cases could go undetected or unreported."
                },
                {
                    "factor": "Potential for Underdetection and Asymptomatic/Mild Cases",
                    "effect": "Slightly increases probability. New CDC review suggests asymptomatic/mild infections can occur and may be missed by surveillance focused on symptomatic cases. If there is a sudden shift or expansion in surveillance (e.g., seroprevalence studies, mass testing in high-risk populations), case counts could rise, but not likely to the degree needed to reach 10,000."
                },
                {
                    "factor": "Base Rate of Secondary (Human-to-Human) Transmission",
                    "effect": "Strongly decreases probability. To date, no confirmed efficient human-to-human transmission in the US; clusters investigated have not shown sustained spread, and the CDC and WHO continue to report low risk."
                }
            ],
            "no_scenario": "H5N1 continues to circulate in birds and cattle, with sporadic human spillover cases detected primarily among agricultural workers. Despite occasional clusters or isolated cases with unclear exposure, there is no sustained human-to-human transmission. CDC reporting remains hampered but resumes in time to list cumulative cases well below 10,000 by year-end 2025. Mild/asymptomatic infections remain underdetected but do not result in a reporting surge. The public health risk remains low.",
            "yes_scenario": "A key mutation (e.g., HA Q226L) emerges in US H5N1 strains, enabling efficient human-to-human transmission. This leads to sustained chains of transmission, resulting in exponential growth in detected/probable cases over months (e.g., a superspreading event in a congregate setting or agricultural community). Enhanced surveillance (including for mild/asymptomatic cases) and public health emergency response drive rapid case detection and reporting, with cumulative confirmed/probable cases surpassing 10,000 before January 1, 2026.",
            "final_reasoning": "The base rate for CDC-reported human H5 infections in the US is extremely low, with only 70 cases over nearly two years and no evidence of a recent surge or exponential trend. Despite intense epizootic activity in birds and cattle, and some theoretical risk posed by viral adaptation (especially given the genetic findings on HA mutations), there is no evidence to date of the key shift to sustained human-to-human transmission in the US. CDC and WHO continue to assess public risk as low, with nearly all human cases linked to direct animal exposure. While underdetection of mild/asymptomatic cases is possible, the question concerns only CDC-reported confirmed/probable cases, and current reporting capacity is impaired by the federal shutdown. Even a hypothetical increase in surveillance is unlikely to generate the >100-fold increase in case detection required to reach 10,000 cases within 13 months, barring a fundamental and unprecedented viral shift. Thus, the probability is extremely low, but not zero, as a single-point mutation could, in principle, trigger a pandemic scenario. This warrants a small, nonzero probability reflecting the 'fat tail' risk of viral evolution, but the overwhelming weight of evidence supports a strong status quo bias.",
            "final_probability": 1
        },
        "CDCInfectiousDiseaseSurveillance (NationalNotifiableDiseasesSurveillanceSystem)": {
            "time_to_resolution": "Approximately 1 year and 2 months (until December 31, 2025)",
            "perspective_relevance": "As an expert in CDC Infectious Disease Surveillance (NNDSS), I have in-depth knowledge of how the CDC defines, tracks, and publicly reports notifiable disease cases\u2014including the nuances of case definitions (confirmed, probable, suspected), reporting lags, and the operational realities affecting data flow during crises. I am familiar with the base rates for emerging zoonoses, the impact of surveillance system disruptions, and the historical thresholds for explosive case growth. This perspective is crucial for evaluating both the technical and practical likelihood of the CDC reporting >10,000 human H5 cases within the specified timeframe.",
            "status_quo": "Since 2024, the CDC has reported a cumulative total of around 70 confirmed/probable human H5 cases in the US, with the vast majority linked to direct animal exposure rather than human-to-human transmission. No evidence of sustained human-to-human transmission has been detected; all prior years have seen case counts in the low dozens per annum. The status quo trajectory is one of gradual, occupationally-limited spillovers with no exponential growth.",
            "perspective_derived_factors": [
                {
                    "factor": "Base rate of confirmed/probable H5 human cases in the US",
                    "effect": "Strongly decreases probability. Historically, the US has not approached anywhere near 10,000 cases; current totals are in the low dozens, and no prior zoonotic flu in the US has ever reached this scale within a year barring pandemic adaptation."
                },
                {
                    "factor": "Absence of sustained human-to-human transmission",
                    "effect": "Strongly decreases probability. CDC and WHO both report no evidence of efficient or sustained human-to-human transmission. Nearly all cases involve direct animal exposure; without adaptation for human-to-human spread, reaching 10,000 is virtually impossible."
                },
                {
                    "factor": "Recent viral genetic adaptation and risk of mutation",
                    "effect": "Slightly increases probability. The Science paper highlights that only a single mutation could enable human-adapted binding, which theoretically could allow a jump to exponential human transmission, but no such adaptation has been observed to date."
                },
                {
                    "factor": "Surveillance system limitations and reporting delays (esp. during government shutdown)",
                    "effect": "Slightly decreases probability. The ongoing government shutdown has hampered CDC data collection and reporting; while this might delay detection, it also makes a sudden, untracked explosion in reported cases unlikely to go unremarked, as hospitalizations would surge."
                },
                {
                    "factor": "International context and outbreaks in animals",
                    "effect": "Marginally increases probability. Widespread outbreaks in poultry and mammals globally increase zoonotic risk, but the lack of human-to-human clusters even in high-exposure settings is reassuring."
                },
                {
                    "factor": "Evidence of asymptomatic or mild cases and possible under-ascertainment",
                    "effect": "Marginally increases probability. Some asymptomatic infections have been detected, but CDC reporting standards require lab confirmation for inclusion; even with some under-ascertainment, reaching 10,000 reported, lab-confirmed/probable cases would require an enormous, unprecedented jump."
                },
                {
                    "factor": "CDC case definition and reporting practices",
                    "effect": "Strongly decreases probability. CDC does not count suspected cases; only confirmed/probable cases are included. The question explicitly excludes estimates and requires direct CDC reporting before January 1, 2026."
                }
            ],
            "no_scenario": "The virus continues to circulate among birds and spill over sporadically to humans with direct animal contact (mainly farm workers, veterinarians, etc.), but no sustained human-to-human transmission emerges. Case counts rise gradually, perhaps reaching into the low hundreds if animal outbreaks intensify, but fall far short of 10,000. CDC reporting remains accurate but may be delayed due to operational issues.",
            "yes_scenario": "A mutation occurs (e.g., the Q226L hemagglutinin change), enabling efficient human-to-human transmission. An uncontained outbreak or pandemic ensues within the US, with exponential growth in cases that are confirmed/probable and reported by the CDC before January 1, 2026. This would represent a paradigm-shifting event, likely accompanied by widespread hospitalizations and international alarm.",
            "final_reasoning": "The base rate for this magnitude of H5 human case reporting in the US is essentially zero absent pandemic adaptation. All available evidence\u2014including CDC and international surveillance, epidemiological investigations, and the lack of clusters\u2014indicates that the virus has not yet evolved sustained human-to-human transmissibility. While the theoretical risk exists (as highlighted by genetic studies), and while animal outbreaks are intense and spillover is ongoing, there is no empirical indication that a jump to mass human transmission is imminent. Even with some under-ascertainment or reporting lag due to federal shutdown, the leap from dozens to >10,000 lab-confirmed/probable cases within a year would require a major, obvious epidemiological shift. The status quo strongly favors a 'No' resolution, and only a truly extraordinary and unprecedented event (a pandemic-level adaptation) would allow the threshold to be crossed. As such, I assign a very low probability, consistent with the base rate and current evidence.",
            "final_probability": 1
        },
        "CDCInfectiousDiseaseSurveillance (CaseDefinitionStandards)": {
            "time_to_resolution": "Approximately 1 month and 3 weeks, until January 1, 2026.",
            "perspective_relevance": "As an expert in CDC Infectious Disease Surveillance and Case Definition Standards, I can precisely interpret how the CDC counts and reports confirmed and probable human H5 cases. My expertise allows for nuanced consideration of CDC protocols, reporting lags, and the likelihood of definitional changes or data artifacts that could dramatically affect case tallies.",
            "status_quo": "As of December 2024, CDC had reported 58 US human H5 cases for the year; by mid-2025, about 70 total cumulative cases were reported. Historically, US annual H5 human cases have been in the single or double digits, with no precedent for large-scale outbreaks or massive case count surges among humans.",
            "perspective_derived_factors": [
                {
                    "factor": "Base rate of H5 human cases",
                    "effect": "Strongly decreases probability; base rate is extremely low, with cumulative US cases since 2022 totaling only 70\u201380, and no indication of exponential human case growth."
                },
                {
                    "factor": "Current status of transmission (no sustained human-to-human spread)",
                    "effect": "Decreases probability; CDC and global surveillance have not detected sustained human-to-human transmission, and nearly all cases are animal-exposed."
                },
                {
                    "factor": "CDC surveillance/reporting capacity amid government shutdown",
                    "effect": "Slightly increases probability of undercount, but does NOT increase the probability of CDC reporting 10,000+ cases; if anything, the shutdown impedes data flow and makes an explosive reported increase less likely."
                },
                {
                    "factor": "Potential for mutation (single mutation could enable human adaptation)",
                    "effect": "Very slightly increases probability; while plausible, there\u2019s no evidence as of November 2025 that such a mutation has occurred and led to explosive, reportable human case numbers."
                },
                {
                    "factor": "Surveillance definitions (confirmed/probable vs. suspected/asymptomatic)",
                    "effect": "Decreases probability, since only confirmed and probable cases count, and CDC typically requires lab confirmation or strong epidemiologic link; asymptomatic or seropositive-only cases are not routinely added to the official case count."
                },
                {
                    "factor": "News of increased animal outbreaks and rare human cases without clear exposures",
                    "effect": "Marginally increases probability, but these have not translated into large clusters or exponential human case growth."
                },
                {
                    "factor": "Recent review showing asymptomatic human H5N1 infections and possible limited transmission",
                    "effect": "Slightly increases probability, since unrecognized mild/asymptomatic cases may exist; however, surveillance systems and CDC reporting practices are not set up to count thousands of such cases unless there is a major shift in approach."
                }
            ],
            "no_scenario": "H5 avian influenza remains primarily an animal health crisis, with sporadic zoonotic spillover to high-risk, exposed individuals (e.g., farm workers). No sustained human-to-human transmission occurs, and the CDC continues to report confirmed/probable human H5 cases in the tens or low hundreds at most\u2014well below the 10,000 threshold. Surveillance definitions and reporting practices remain unchanged.",
            "yes_scenario": "A critical mutation allows efficient human-to-human transmission, causing a large-scale outbreak or pandemic in the United States before January 1, 2026. The CDC shifts its surveillance and reporting to count thousands of mild, probable, or laboratory-confirmed cases, possibly due to mass testing in the general population. Alternatively, a sudden definitional change or data artifact causes the CDC to report a surge in confirmed/probable cases exceeding 10,000 before the deadline.",
            "final_reasoning": "The base rate of US human H5 cases is extremely low, with only 70 reported since 2022 and no evidence of exponential growth. Current surveillance and case definitions focus on confirmed/probable cases, not seroprevalence or suspected/asymptomatic infections. Animal outbreaks are severe, and a few human cases without clear exposures are worrying but have not triggered a cascade of human infections. The genetic evidence for a potential 'single mutation' pandemic trigger is concerning, but there is no indication this has occurred in the wild. Even if asymptomatic or mild cases are more common than recognized, CDC reporting would not suddenly jump to 10,000+ cases absent massive, sustained human-to-human transmission and a major change in surveillance or definitions. The current government shutdown and CDC operational limitations, if anything, reduce the likelihood of a reporting surge. Given the historical base rate, lack of human transmission, and case definition constraints, the probability of CDC reporting \u226510,000 human H5 cases before January 1, 2026, is extremely low\u2014barring an unprecedented and currently unobserved epidemiological shift.",
            "final_probability": 1
        },
        "AnimalHealthPolicyUnitedStates (USDAAPHISSurveillance)": {
            "time_to_resolution": "approximately 1 year and 2 months until January 1, 2026",
            "perspective_relevance": "As an expert in Animal Health Policy in the United States, with direct insight into USDA APHIS surveillance systems, I am well-placed to assess the plausibility of CDC reporting a massive surge in human H5 cases. My expertise allows me to weigh the realities of US surveillance capacity, outbreak investigation protocols, reporting pipelines, and the typical base rates for zoonotic influenza spillover events\u2014factors crucial for distinguishing true risk from media-driven alarm.",
            "status_quo": "As of November 2025, CDC has reported approximately 70 confirmed human H5 cases since 2024, with historic annual averages for all H5 in the US rarely exceeding a handful per year prior to this outbreak. The status quo is slow, sporadic zoonotic spillover, no evidence for sustained human transmission, and CDC reporting on the order of tens (not thousands) of cases per year.",
            "perspective_derived_factors": [
                {
                    "factor": "Base Rate of Human H5 Infections in the US",
                    "effect": "Strongly decreases probability. Historically, even during the worst animal outbreaks, US confirmed/probable human H5 cases have been in the single or low double digits per year. There is no precedent for thousands, let alone 10,000+ cases in less than 14 months."
                },
                {
                    "factor": "Lack of Efficient Human-to-Human Transmission",
                    "effect": "Strongly decreases probability. All epidemiological and genetic evidence, including CDC and Nature reports, indicate no sustained human-to-human transmission. The vast majority of cases are linked to direct animal exposure."
                },
                {
                    "factor": "CDC Surveillance and Reporting Capacity",
                    "effect": "Moderately decreases probability. While the ongoing government shutdown and resource constraints could reduce data completeness, the question specifically refers to reported confirmed/probable cases, and the CDC's reporting pipeline is more likely to undercount than overcount."
                },
                {
                    "factor": "Potential for Under-ascertainment or Surveillance Expansion",
                    "effect": "Slightly increases probability. The review in CIDRAP highlights potential for asymptomatic or mild cases to go undetected, and argues for more robust surveillance. If the US were to radically expand testing (e.g., for all exposed farmworkers), more cases could be captured, but scaling to 10,000 would still require either efficient human transmission or a quantum leap in surveillance effort."
                },
                {
                    "factor": "Mutation Risk (Viral Adaptation)",
                    "effect": "Slightly increases probability. The Science/ScienceDaily article notes that a single mutation could shift binding specificity to humans, which is a theoretical risk. However, no evidence has emerged of such a mutation driving a current outbreak, and CDC continues to rate public health risk as low."
                },
                {
                    "factor": "International Patterns and Global Base Rates",
                    "effect": "Decreases probability. Even in countries with larger outbreaks (Asia, Europe), human H5 case counts remain in the hundreds over years, not thousands per year. No other country has observed a sudden leap to 10,000+ cases absent pandemic-level human transmission."
                },
                {
                    "factor": "Severity and Symptom Profile",
                    "effect": "Decreases probability. Most US cases have been mild and detected mainly in high-risk, monitored populations. With no evidence of widespread subclinical transmission, a sudden surge to 10,000 confirmed/probable cases would require either an abrupt shift in clinical presentation leading to mass testing or a dramatic change in pathogen behavior."
                },
                {
                    "factor": "Current Animal Outbreak Magnitude",
                    "effect": "Increases probability slightly. The US is experiencing record levels of H5N1 in poultry, wild birds, and cattle, creating many more opportunities for spillover. However, without a corresponding shift in transmission dynamics, this alone is insufficient for a 10,000-case leap."
                }
            ],
            "no_scenario": "Despite continued large-scale H5N1 outbreaks in US poultry and dairy, human cases remain rare and linked to direct animal exposure. Enhanced surveillance detects a few dozen to a few hundred additional cases over the next year, but the total remains well below 10,000. No evidence emerges of efficient human-to-human transmission or mass subclinical infection. CDC reporting remains limited by resource constraints, and the status quo of slow, sporadic spillover holds.",
            "yes_scenario": "A dramatic viral mutation (potentially the HA Q226L noted in Science) enables sustained human-to-human transmission, or a massive, nationwide expansion of surveillance and testing uncovers large numbers of previously undetected mild/asymptomatic cases, possibly fueled by ongoing animal outbreaks and environmental exposure. CDC rapidly updates case definitions and reporting, and the case count accelerates into the thousands per month, surpassing 10,000 before the end of 2025.",
            "final_reasoning": "Base rates, virological evidence, and CDC's own reporting all point to a scenario where 10,000+ confirmed/probable US human H5 cases before 2026 would be unprecedented and would require either a fundamental shift in the virus's biology (efficient human-to-human transmission) or a radical, nationwide expansion of surveillance with mass testing of exposed persons. Neither is evident in current CDC guidance, scientific reporting, or historical precedent. Recent news shows surging animal outbreaks and rare human cases, but no sign of a pandemic-level event. Even with under-ascertainment and possible increase via surveillance, the scale required (>140-fold increase in 13 months) is implausible absent a dramatic and widely publicized change. Thus, while not strictly impossible, the probability is vanishingly low.",
            "final_probability": 1
        },
        "AnimalHealthPolicyUnitedStates (EmergencyDiseaseReportingProtocols)": {
            "time_to_resolution": "Just under 14 months (from November 7, 2025, to January 1, 2026)",
            "perspective_relevance": "As an expert in AnimalHealthPolicyUnitedStates (EmergencyDiseaseReportingProtocols), my perspective is highly relevant because CDC human case reporting is tightly governed by U.S. notifiable disease protocols, and historical animal-to-human zoonoses trends in the U.S. inform expectations. Familiarity with emergency response and reporting lag during crises (e.g., federal shutdowns, pandemics) gives insight into the reliability and pace of official CDC case counts.",
            "status_quo": "As of December 2024, the U.S. CDC had reported 58 human H5 cases for 2024 YTD, and as of mid-2025, total U.S. cases were around 70, with no evidence of large-scale human-to-human transmission. Case counts have increased, but remain far below 10,000.",
            "perspective_derived_factors": [
                {
                    "factor": "Historical base rate of CDC-reported zoonotic influenza (H5) human cases",
                    "effect": "Strongly decreases probability; prior outbreaks have never approached 10,000 confirmed/probable CDC-reported human H5 cases in a year or even over several years, with cumulative U.S. cases in the low hundreds globally since 1997."
                },
                {
                    "factor": "Current state of H5N1 adaptation to humans and transmissibility",
                    "effect": "Decreases probability; while there is concern about a single mutation potentially allowing more efficient human infection, as of now, there is no evidence of sustained human-to-human transmission in the U.S. or globally."
                },
                {
                    "factor": "CDC reporting protocols and capacity during government shutdown",
                    "effect": "Slightly decreases probability; shutdown-induced delays make it less likely that rapidly expanding case numbers would be identified, processed, and counted in real time, and CDC is unlikely to over-report in the absence of clear evidence."
                },
                {
                    "factor": "Animal outbreak severity and mammalian spillover (esp. to cattle)",
                    "effect": "Slightly increases probability; the spread to cattle and evidence of rare asymptomatic or mild human cases raise the possibility of undetected cases, but not necessarily reported ones, given criteria for confirmed/probable status."
                },
                {
                    "factor": "Recent scientific findings (e.g., single mutation enabling human adaptation)",
                    "effect": "Marginally increases probability; although concerning, such a mutation has not yet been documented as widespread in the U.S. and would need to both occur and spread efficiently to spark a large outbreak within the forecast window."
                },
                {
                    "factor": "CDC case definition and surveillance emphasis on symptomatic/known exposure cases",
                    "effect": "Decreases probability; as surveillance is primarily among those with occupational exposure or symptoms, and the vast majority of Americans are not at direct risk, large numbers of mild/asymptomatic cases are unlikely to be counted."
                }
            ],
            "no_scenario": "Cases continue to rise slowly, with occasional clusters among animal workers and sporadic cases in the broader population, but without efficient human-to-human transmission. CDC-reported cumulative cases remain in the low hundreds by the end of 2025, far below 10,000. Even if mild/asymptomatic cases are more common, they are not detected/reported under current surveillance and reporting protocols.",
            "yes_scenario": "A critical mutation occurs (e.g., Q226L in hemagglutinin), resulting in efficient human-to-human transmission in the U.S. This leads to a surge of symptomatic and tested cases with rapid CDC reporting, and a large outbreak occurs, resulting in over 10,000 confirmed/probable cases being reported before January 1, 2026.",
            "final_reasoning": "Base rates for CDC-reported H5 human infections are extremely low, with only ~70 reported in the U.S. since March 2024. There is currently no evidence of efficient human-to-human transmission, and CDC reporting protocols focus on confirmed/probable symptomatic cases, not serological or modeled estimates. While the animal outbreak is severe and mammalian spillover is increasing, the absence of exponential growth in reported human cases and the continued CDC assessment of 'low' public health risk are strong anchors. The single-mutation risk is real but not yet realized; even if it happens soon, the time window is short (14 months) to reach 10,000 CDC-confirmed/probable cases. The government shutdown also slows reporting, not increases it. Therefore, the chance of CDC reporting 10,000 or more H5 human cases in the U.S. before January 1, 2026, is extremely low barring a sudden, unprecedented pandemic. I estimate the probability at 1%.",
            "final_probability": 1
        },
        "Epidemiology (InfectiousDiseaseModeling)": {
            "time_to_resolution": "Approximately 8 weeks (until January 1, 2026)",
            "perspective_relevance": "As an expert in infectious disease modeling, I bring a quantitative, base-rate-driven approach to forecasting, with a focus on transmission dynamics, zoonotic spillover, surveillance/reporting infrastructure, and mutation risk. My perspective emphasizes the statistical likelihood of explosive outbreaks based on historical data, the current surveillance environment, and the known biology of H5 viruses.",
            "status_quo": "As of now, the CDC has reported approximately 70 human H5 cases in the US over almost two years (2024\u20132025), with the vast majority linked to direct animal exposure, no confirmed sustained human-to-human transmission, and a case count several orders of magnitude below the 10,000 threshold.",
            "perspective_derived_factors": [
                {
                    "factor": "Base Rate of Confirmed Human H5 Infections in the US",
                    "effect": "Strongly decreases probability. The historical rate is extremely low (70 cases in ~20 months), and reaching 10,000 would require an unprecedented, exponential surge."
                },
                {
                    "factor": "Lack of Sustained Human-to-Human Transmission",
                    "effect": "Strongly decreases probability. All available data and CDC statements indicate no confirmed efficient human-to-human spread, which is necessary for a case explosion."
                },
                {
                    "factor": "Current Surveillance and Reporting Limitations",
                    "effect": "Modestly decreases probability. CDC data collection has been hampered by the government shutdown, but essential reporting continues, and there is no indication of large undetected clusters."
                },
                {
                    "factor": "Mutation Risk (E.g., Q226L in Hemagglutinin)",
                    "effect": "Slightly increases probability. Scientific literature notes that a single mutation could enable human adaptation, but as of now, no such event has been detected in the US. The probability of this occurring and leading to a major outbreak in the next 8 weeks is very low but not zero."
                },
                {
                    "factor": "Recent Increase in Animal Outbreaks and Mammalian Spillover",
                    "effect": "Slightly increases probability. There is a growing reservoir in birds, cattle, and some mammals, which increases opportunities for zoonotic spillover and adaptation, but so far, human spillover events remain rare and not self-sustaining."
                },
                {
                    "factor": "Potential for Asymptomatic or Mild Cases",
                    "effect": "Marginally increases probability. Recent reviews suggest some asymptomatic or undetected H5 infections, but even accounting for under-reporting, the gap to 10,000 is immense, and only confirmed/probable cases count for resolution."
                }
            ],
            "no_scenario": "The virus continues to circulate in animal populations with occasional spillover to humans, but no efficient human-to-human transmission emerges. Human cases remain sporadic, tied to animal exposure, and the cumulative case count remains well below 10,000 by January 1, 2026.",
            "yes_scenario": "A major viral mutation (such as Q226L in hemagglutinin) occurs in the US, resulting in efficient human-to-human transmission. A large, rapidly spreading outbreak develops, with thousands of confirmed/probable cases reported by CDC before January 1, 2026. This would require an immediate and dramatic shift in epidemiological patterns, which there is currently no evidence for.",
            "final_reasoning": "Base rates for human H5 infections in the US are vanishingly low, with only 70 cases to date and no evidence of sustained transmission. The threshold of 10,000 cases would require a rapid, catastrophic pandemic-level event within the next two months, which is not supported by current surveillance, outbreak patterns, or mutation reports. While there are theoretical risks from mutation and growing animal reservoirs, there is no indication such a leap has occurred or is imminent. Surveillance limitations due to the government shutdown do not appear sufficient to mask thousands of cases, as severe outbreaks would show up in hospitalizations and mortality. The status quo strongly favors a 'no' outcome. The only plausible path to 10,000 cases is a sudden, explosive mutation event, which remains highly improbable within the short time frame.",
            "final_probability": 1
        },
        "Epidemiology (BasicReproductionNumberR0)": {
            "time_to_resolution": "Approximately 8 weeks (question closes Jan 1, 2026; today is Nov 7, 2025)",
            "perspective_relevance": "As an epidemiologist specializing in the basic reproduction number (R0), my expertise is directly relevant to understanding and forecasting the spread of infectious diseases, especially zoonoses like H5 avian influenza. My knowledge of transmission dynamics, mutation effects on viral fitness, surveillance artifacts, and the impact of public health responses allows me to evaluate the likelihood of rapid, large-scale human outbreaks.",
            "status_quo": "As of December 2024, there were 58 US human H5 cases reported by CDC for the year, with approximately 70 cumulative US cases by mid-2025. Cases to date are primarily linked to animal (poultry/cattle) exposures, with no confirmed sustained human-to-human transmission. CDC and WHO continue to assess the risk to the general public as low.",
            "perspective_derived_factors": [
                {
                    "factor": "Current R0 for H5 in humans",
                    "effect": "Decreases probability. Multiple studies and CDC reports indicate R0 remains <1 for human-to-human transmission, meaning chains of transmission are not self-sustaining and most cases are dead ends."
                },
                {
                    "factor": "Viral genetic changes/adaptability",
                    "effect": "Slightly increases probability. A recent study highlights a single mutation (Q226L in hemagglutinin) could enable human receptor binding, raising theoretical risk; however, no evidence yet that such strains are prevalent or transmitting efficiently in humans."
                },
                {
                    "factor": "High animal (especially mammal) burden and exposure",
                    "effect": "Slightly increases probability. High levels of infection in poultry, wild birds, and now dairy cattle increase spillover risk, and may increase the chance of mutations."
                },
                {
                    "factor": "CDC surveillance/reporting limitations",
                    "effect": "Decreases probability. The federal government shutdown has slowed CDC data updates and limited surveillance, but the question counts only individually identified, confirmed/probable cases, not modeled estimates. Under-detection is possible, but the scale needed to reach 10,000 is extreme."
                },
                {
                    "factor": "Historical base rates for zoonotic avian flu outbreaks",
                    "effect": "Strongly decreases probability. No instance in recorded history of tens of thousands of confirmed/probable US human cases occurring within a single year, even during high-animal-burden years."
                },
                {
                    "factor": "Potential for asymptomatic/mild cases and undetected transmission",
                    "effect": "Slightly increases probability. Recent review shows asymptomatic infection and limited human-to-human transmission are possible in close contacts, but no evidence of large, sustained outbreaks. US surveillance focuses on symptomatic or exposed individuals, so mild/asymptomatic cases could be missed, but massive case undercounting to this scale is unlikely given public health vigilance."
                },
                {
                    "factor": "Time remaining to resolution",
                    "effect": "Decreases probability. With under two months left, and no sign of exponential growth or sustained transmission in humans, there is limited time for a scenario to unfold that could generate >9,900 new cases (from ~70)."
                }
            ],
            "no_scenario": "H5 continues to circulate widely among birds and mammals, and sporadic spillover to humans occurs\u2014primarily in high-risk occupational settings (farmworkers, culling crews, dairy workers)\u2014but there is no significant increase in human-to-human transmission. CDC continues to report low, incremental case numbers, remaining well below 10,000 by January 1, 2026.",
            "yes_scenario": "A critical mutation (such as Q226L in HA) emerges and establishes itself in circulating US H5 strains, resulting in a sudden, dramatic rise in human transmissibility (R0>1). This leads to widespread community outbreaks, thousands of symptomatic cases, and rapid, large-scale CDC reporting of confirmed/probable cases, crossing the 10,000 threshold within two months. Alternatively, the CDC radically changes its surveillance definitions or testing protocols, leading to a massive surge in reported case numbers (unlikely per fine print).",
            "final_reasoning": "The US has only reported ~70 confirmed/probable H5 cases over more than a year, with no evidence of sustained human-to-human spread. While the animal outbreak is severe, and there is theoretical concern over viral adaptation, there has not yet been a breakthrough mutation leading to exponential human transmission. The R0 for H5 in humans remains well below 1, and public health surveillance, despite some data lags, has not indicated a surge in unexplained respiratory illnesses linked to H5. The base rate for zoonotic avian influenza outbreaks crossing into thousands of US confirmed/probable cases in less than two months is essentially zero. While under-detection and mild/asymptomatic cases can occur, the scale required to reach 10,000 is orders of magnitude above current trends, and there is no evidence of an abrupt change in transmission or reporting definitions. Therefore, the probability that CDC will report 10,000 or more confirmed/probable H5 avian influenza cases in the US before Jan 1, 2026, is extremely low.",
            "final_probability": 1
        },
        "Epidemiology (OneHealthConcept)": {
            "time_to_resolution": "Approximately 1 year and 2 months (until December 31, 2025).",
            "perspective_relevance": "As an expert in Epidemiology with a One Health Concept perspective, I integrate data from human, animal, and environmental health. This is particularly relevant for avian influenza, which crosses species barriers and is influenced by agricultural practices, wildlife dynamics, and human-animal interfaces. My expertise enables nuanced assessment of both zoonotic risk and surveillance/reporting realities.",
            "status_quo": "As of December 11, 2024, the CDC had reported 58 human H5 cases in the US for 2024 YTD, and as of mid-2025, cumulative US cases were ~70. The base rate is thus on the order of 50\u2013100 confirmed/probable human cases per year.",
            "perspective_derived_factors": [
                {
                    "factor": "Zoonotic Transmission Patterns",
                    "effect": "Increases probability only if there is a significant shift (e.g., adaptation for efficient human-to-human transmission), but currently, the virus remains poorly adapted for efficient human-to-human spread. This keeps probability low."
                },
                {
                    "factor": "Changes in Surveillance and Reporting",
                    "effect": "Could increase probability if there is a sudden massive scale-up in testing, detection of asymptomatic/mild cases, or a major definitional change\u2014but current CDC reporting practices are focused on confirmed/probable symptomatic cases, and there is no indication of imminent change."
                },
                {
                    "factor": "Viral Mutation/Adaptation",
                    "effect": "A single mutation (Q226L) can increase human receptor binding, but there is no evidence this has occurred at scale in the US. If it happened, a rapid surge in human cases could occur, but current evidence still points to low human-to-human transmission."
                },
                {
                    "factor": "Animal Outbreak Magnitude and Human Exposure",
                    "effect": "Outbreaks in birds and cattle have become much more frequent and widespread, increasing the number of at-risk individuals. However, the number of human cases remains small relative to the scale of animal outbreaks, reflecting limited cross-species transmission."
                },
                {
                    "factor": "Public Health Disruption (e.g., CDC Shutdown)",
                    "effect": "May decrease probability of reporting (cases missed/undercounted) but not the probability of true infections. If reporting is further delayed or disrupted, even a true surge might not be captured in official CDC statistics before the deadline."
                },
                {
                    "factor": "Historical Base Rates",
                    "effect": "Strongly decreases probability: In the past two decades, US confirmed/probable H5 cases in humans have never approached 10,000 in a single year, nor globally in a single country."
                }
            ],
            "no_scenario": "H5N1 continues to circulate widely among US poultry, dairy cattle, and wild birds, causing significant economic losses and culling, but the virus does not acquire mutations enabling efficient human-to-human transmission. Human cases continue to occur sporadically, primarily among agricultural workers with direct animal contact, with total CDC-reported confirmed/probable cases remaining in the double or low triple digits by year-end 2025. No reporting shift or mass-scale testing of asymptomatic/mildly symptomatic individuals occurs. CDC reporting remains delayed but continuous, with official tallies far below 10,000.",
            "yes_scenario": "A dramatic, unprecedented event occurs: The virus acquires a mutation enabling efficient human-to-human transmission (e.g., Q226L in hemagglutinin becomes widespread), triggering sustained outbreaks in the general population. Alternatively, a massive change in CDC surveillance results in the identification and reporting of tens of thousands of mild/asymptomatic cases (e.g., through broad-based serological or PCR screening). In either scenario, the CDC publicly reports 10,000 or more confirmed/probable H5 cases before January 1, 2026.",
            "final_reasoning": "The base rate for CDC-reported human H5 cases in the US is extremely low (tens to low hundreds annually), even in the face of unprecedented animal outbreaks. No evidence currently exists for efficient human-to-human transmission or a dramatic reporting expansion. The virus remains primarily zoonotic, with most human cases linked to direct animal contact. While the One Health perspective highlights the pandemic potential if a key mutation arises, the time to question resolution is only about 14 months and the status quo is entrenched. Even with ongoing animal outbreaks and some evidence for underdiagnosed/asymptomatic cases, the CDC is unlikely to report >10,000 confirmed/probable cases barring an extraordinary and rapid change in epidemiology or surveillance. The greatest uncertainty lies in viral evolution, but such a leap in transmissibility and case detection in this timeframe is historically unprecedented and unsupported by current data. Therefore, the probability remains extremely low.",
            "final_probability": 1
        },
        "PublicHealth (SurveillanceSystemsTheory)": {
            "time_to_resolution": "Approximately 1 year and 2 months (until December 31, 2025)",
            "perspective_relevance": "As an expert in Public Health Surveillance Systems Theory, I bring a deep understanding of how infectious disease cases are detected, classified, and reported via national surveillance networks. I can critically evaluate what case numbers mean, how they are ascertained, and the likelihood of sudden shifts in reporting trends or surveillance sensitivity. I also bring awareness of systemic biases, underreporting, the gap between infection and confirmed/probable case reporting, and the comparative analysis of historic zoonotic spillovers.",
            "status_quo": "H5 avian influenza cases in humans remain rare in the United States, with only 58 cases reported by CDC in 2024 and a cumulative total of around 70 through mid-2025. These have mostly been linked to direct animal exposure, with no confirmed sustained human-to-human transmission. CDC currently assesses public health risk as 'low.'",
            "perspective_derived_factors": [
                {
                    "factor": "Base Rate of Human H5 Infections in US",
                    "effect": "Strongly decreases probability. Despite surges in poultry/cattle infections and some mammalian spillover, confirmed/probable human cases remain extremely rare, with only tens of cases reported annually and no exponential growth trend."
                },
                {
                    "factor": "Current Surveillance Sensitivity and Focus",
                    "effect": "Moderately decreases probability. US surveillance systems focus on symptomatic, confirmed, or probable cases from known exposures. Asymptomatic and mild cases likely go undetected, but this does not affect the official CDC case count per the resolution criteria."
                },
                {
                    "factor": "Absence of Sustained Human-to-Human Transmission",
                    "effect": "Strongly decreases probability. All data and CDC statements indicate no efficient person-to-person transmission, which is required for a case explosion to >10,000."
                },
                {
                    "factor": "Potential for Viral Mutation (e.g., Q226L in HA)",
                    "effect": "Very slightly increases probability. While the Science article notes a single mutation could shift host specificity, such a mutation has not been observed in US human cases to date, and even if it occurred, it would need to circulate widely and evade detection long enough to cause thousands of cases."
                },
                {
                    "factor": "Recent Increases in Animal Outbreaks and Mammalian Spillover",
                    "effect": "Slightly increases probability. Although animal cases and mammalian spillover are rising, historic zoonotic outbreaks (even with mammalian hosts) have rarely led to large human outbreaks without concurrent mutations and clear evidence of efficient human-to-human transmission."
                },
                {
                    "factor": "Disruption in Public Health Surveillance (e.g., due to government shutdown)",
                    "effect": "Slightly increases probability of under-ascertainment but not of reported case explosion. If anything, it may reduce reported case counts, not inflate them."
                }
            ],
            "no_scenario": "Despite ongoing large-scale outbreaks in poultry, cattle, and wild birds, human H5 case numbers in the US remain in the dozens to low hundreds through 2025. There is no evidence of sustained human-to-human transmission, and CDC case counts remain well below 10,000. Even if more mild or asymptomatic cases occur, they are not captured as confirmed/probable and thus do not count toward the resolution criteria.",
            "yes_scenario": "A major viral mutation or reassortment event occurs\u2014such as the Q226L mutation in hemagglutinin\u2014enabling efficient human-to-human transmission. This triggers a rapidly spreading outbreak in the general population, with thousands of symptomatic cases identified, tested, and confirmed by the CDC. Surveillance is ramped up, and the CDC reports >10,000 confirmed/probable human cases before January 1, 2026. Alternatively, a change in surveillance/reporting protocol identifies a large pre-existing burden, but this is unlikely given current trends.",
            "final_reasoning": "The base rate for such a dramatic jump in reported human H5 cases in the US is extremely low. Despite major outbreaks in animals, decades of data show that zoonotic H5 transmission to humans is rare and usually associated with direct, high-exposure settings. There are no signs of exponential human case growth or efficient person-to-person spread. Surveillance focuses on confirmed/probable cases with laboratory or strong epidemiological evidence, and under-ascertainment of mild cases will not affect the CDC's reported case count as defined by the resolution criteria. Even with ongoing animal outbreaks and spillover to mammals, we would expect more than a 100-fold increase in confirmed/probable human cases only if a mutation enabling efficient human transmission occurs and spreads undetected for weeks\u2014a low probability event within the next year, especially given the global attention and ongoing genomic surveillance. The disruption in public health operations (e.g., due to the government shutdown) would more likely delay or reduce reporting, not inflate it. In summary, unless a true and dramatic shift in viral transmissibility to and among humans occurs\u2014something unprecedented and not currently observed\u2014the probability of CDC reporting over 10,000 confirmed/probable H5 human cases before Jan 1, 2026 is extremely low.",
            "final_probability": 1
        },
        "PublicHealth (PandemicPreparednessModels)": {
            "time_to_resolution": "Approximately 1 year and 2 months (until December 31, 2025)",
            "perspective_relevance": "As an expert in Public Health with a focus on Pandemic Preparedness Models, I bring an understanding of zoonotic spillover dynamics, surveillance system limitations, base rates for novel influenza emergence, and the operational/practical constraints of public health reporting. My expertise allows me to critically assess the likelihood of rapid escalation in human H5 case counts, interpret the significance of cross-species transmission events, and evaluate the plausibility of sustained human-to-human transmission occurring and being detected in the US in the near term.",
            "status_quo": "The CDC has reported 58 human H5 cases in the US so far in 2024, with the overwhelming majority linked to direct animal exposure, and no confirmed person-to-person transmission. Globally, fewer than 1,000 human H5 cases have been reported over almost three decades, and the US has not previously experienced more than a handful in any prior year. CDC currently assesses public health risk as low. The status quo is slow accumulation of sporadic, animal-exposure-linked cases, not exponential growth.",
            "perspective_derived_factors": [
                {
                    "factor": "Base Rate of Human H5 Cases in the US and Globally",
                    "effect": "Strongly decreases probability; historical precedent shows extremely few cases, even during large animal outbreaks."
                },
                {
                    "factor": "Current Transmission Dynamics (No Sustained Human-to-Human Transmission)",
                    "effect": "Strongly decreases probability; no evidence of efficient person-to-person spread, which would be necessary for thousands of cases."
                },
                {
                    "factor": "Surveillance and Reporting Capacity (Including Outages Due to Shutdown)",
                    "effect": "Slightly decreases probability; reporting lags and system strain make rapid detection of large numbers less likely, and only confirmed/probable cases count."
                },
                {
                    "factor": "Genetic Adaptation Potential (Single Mutation Could Change Host Specificity)",
                    "effect": "Slightly increases probability; scientific findings indicate a single mutation could enable human adaptation, but the probability of this occurring and spreading widely in the next year is low."
                },
                {
                    "factor": "Widespread Animal Reservoirs and Mammalian Infections (Cattle, Cats, etc.)",
                    "effect": "Moderately increases probability; more opportunities for spillover, but so far, human cases remain rare and mostly mild."
                },
                {
                    "factor": "Potential for Asymptomatic or Mild Human Infection and Underascertainment",
                    "effect": "Slightly increases probability; some cases may be missed, but only confirmed/probable are counted for this question, and CDC's surveillance focuses on symptomatic/known exposures."
                },
                {
                    "factor": "Global Outbreak Trends and Pressure on US Agriculture",
                    "effect": "Slightly increases probability; large outbreaks in poultry and cattle increase risk to farm workers, but not at the scale to drive case counts into the thousands absent a transmission shift."
                }
            ],
            "no_scenario": "H5N1 continues to circulate among birds and mammals with sporadic spillover to humans, primarily among agricultural workers with direct animal contact. No significant mutation occurs to enable efficient person-to-person transmission. CDC continues to report new cases in the dozens or low hundreds at most, with the total case count by January 1, 2026 well under 10,000.",
            "yes_scenario": "A critical mutation or genetic reassortment occurs, enabling H5N1 to transmit efficiently between humans (e.g., via respiratory droplets), leading to a rapid outbreak. This is detected by CDC, which begins reporting hundreds to thousands of confirmed/probable cases per week/month, resulting in the cumulative total exceeding 10,000 before January 1, 2026. Alternatively, an unprecedented surge in zoonotic spillovers occurs, with massive outbreaks in agricultural settings and extensive testing/confirmation.",
            "final_reasoning": "The probability that CDC will report 10,000 or more human H5 cases in the US before January 1, 2026 is exceedingly low given current trends and the base rate for novel influenza outbreaks. Despite large animal outbreaks and increased mammalian infections, there is still no evidence of sustained human-to-human transmission, which would be a prerequisite for case numbers in the thousands. Historically, even major zoonotic outbreaks have resulted in only dozens of human cases per year in the US. The scientific finding of a single mutation potentially enabling human adaptation is concerning but represents a hazard, not a high-likelihood event over the next year. The status quo strongly favors a No outcome, barring an extraordinary and unprecedented epidemiological shift. Surveillance and reporting limitations further constrain the likelihood of rapidly detecting and confirming such a large number of cases. The only plausible Yes scenario is a true pandemic emergence, which would likely be detectable via multiple, rapid, severe clusters\u2014a scenario for which there is currently no evidence. Therefore, the justified forecast, reflecting high confidence in the status quo, is extremely low.",
            "final_probability": 1
        },
        "VeterinaryMedicine (ZoonoticDiseaseTransmission)": {
            "time_to_resolution": "Less than 2 months (until January 1, 2026)",
            "perspective_relevance": "As an expert in veterinary medicine with a focus on zoonotic disease transmission, I bring a nuanced understanding of the interfaces between animal reservoirs (especially birds and mammals), viral adaptation, surveillance challenges, and the epidemiological and reporting practices that influence how and when zoonotic spillover events are detected and counted. My expertise also includes knowledge of base rates for zoonotic influenza transmission, public health infrastructure, and the reporting pipelines that define what gets counted as a reportable case.",
            "status_quo": "The CDC has reported 58 human H5 cases in 2024, and about 70 cumulative cases in the US since the start of the outbreak, with no evidence of sustained human-to-human transmission. Historically, the number of confirmed or probable human H5 cases in the US has been extremely low, and no previous outbreak has approached 10,000 confirmed/probable cases in a single year.",
            "perspective_derived_factors": [
                {
                    "factor": "Virus adaptation and human-to-human transmission potential",
                    "effect": "Slightly increases probability if adaptation occurs, but as of now, only limited adaptation has been documented; no evidence of efficient human-to-human transmission in the US, so status quo holds."
                },
                {
                    "factor": "Current outbreak scale in animals and mammals",
                    "effect": "Increases probability of spillover events in exposed populations, but does not by itself support exponential increase to 10,000 cases without a fundamental shift in transmission dynamics."
                },
                {
                    "factor": "CDC case definition and surveillance/reporting bottlenecks",
                    "effect": "Decreases probability: Only confirmed or probable cases count, and the US surveillance focuses on symptomatic/at-risk individuals; asymptomatic or mild cases likely go undetected, so true numbers may be higher, but reported numbers will stay much lower."
                },
                {
                    "factor": "Historical base rates of zoonotic influenza spillover in the US",
                    "effect": "Strongly decreases probability: No precedent for a rapid jump from dozens to thousands of confirmed/probable cases in a matter of weeks without a major epidemiological shift."
                },
                {
                    "factor": "Genetic studies indicating potential for mutation to enable human adaptation",
                    "effect": "Marginally increases probability: Genetic studies highlight risk, but as of now, no evidence this has occurred and led to sustained transmission."
                },
                {
                    "factor": "Current CDC and USDA operational capacity (government shutdown)",
                    "effect": "Decreases probability: Ongoing shutdown impairs surveillance and reporting; if anything, this will delay or suppress case counts, not inflate them."
                }
            ],
            "no_scenario": "Despite widespread H5 outbreaks in birds and cattle, the virus continues to spill over sporadically into humans with direct animal contact, but no adaptation for efficient human-to-human transmission occurs. CDC continues to report dozens or at most low hundreds of confirmed/probable human cases by January 1, 2026, with the US remaining in the status quo of low public health risk.",
            "yes_scenario": "A dramatic shift occurs: H5 virus acquires a critical mutation (e.g., Q226L in hemagglutinin), enabling efficient human-to-human transmission. This leads to a rapid, exponential rise in human cases, with thousands of symptomatic and confirmed/probable cases reported by CDC prior to January 1, 2026. This would likely coincide with high media attention, emergency CDC bulletins, and a declared public health crisis.",
            "final_reasoning": "The base rate for zoonotic avian influenza outbreaks progressing from dozens to over 10,000 CDC-reported confirmed/probable human cases in a matter of weeks is effectively zero in the modern surveillance era. While the current animal outbreak is unprecedented in scale, human cases in the US remain rare and associated with direct animal exposure, not community transmission. Genetic research highlights pandemic potential, but there is no evidence of a breakthrough event having occurred. The ongoing government shutdown and CDC operational challenges will, if anything, suppress reporting rather than lead to a huge spike. Given the short time to resolution and the lack of any indication of a major epidemiological shift, the probability of reaching 10,000 reported human H5 cases in the US before January 1, 2026 is vanishingly small.",
            "final_probability": 1
        },
        "VeterinaryMedicine (VeterinaryPublicHealthSurveillance)": {
            "time_to_resolution": "Approximately 8 weeks (until December 31, 2025)",
            "perspective_relevance": "As an expert in Veterinary Public Health Surveillance, my perspective is critical for understanding both the reporting mechanisms and the epidemiological trajectories of zoonotic diseases such as H5 avian influenza. My experience allows me to interpret the relationship between animal outbreaks, spillover risk to humans, case detection/reporting biases, and the practical limitations of the CDC\u2019s surveillance capacity, especially amid operational disruptions.",
            "status_quo": "As of December 11, 2024, the CDC reported 58 human H5 avian influenza cases in the US for YTD 2024, with cumulative US human H5N1 cases since March 2024 standing at about 70 by mid-2025. Human-to-human transmission remains unconfirmed, and US case counts have been low and mostly linked to direct animal exposure. Historically, annual US human H5 case counts have been in the single or low double digits.",
            "perspective_derived_factors": [
                {
                    "factor": "CDC Surveillance and Reporting Capacity",
                    "effect": "Decreases probability. The ongoing federal shutdown has severely hampered CDC's ability to detect, confirm, and publicly report human cases at scale. Even with a surge in cases, underreporting and delays are likely."
                },
                {
                    "factor": "Zoonotic Transmission and Current Epidemiology",
                    "effect": "Decreases probability. Despite large-scale outbreaks in US poultry and cattle, the jump to humans remains rare and mostly occupational, with no sustained human-to-human transmission. Outbreaks in animals have not translated into explosive human epidemics."
                },
                {
                    "factor": "Mutation Potential and Pandemic Risk",
                    "effect": "Slightly increases probability. The recent Science paper highlights the risk of a single mutation enabling increased human receptor binding. However, there is no evidence this mutation has occurred or is spreading in the US as of now."
                },
                {
                    "factor": "Base Rates and Historical Context",
                    "effect": "Strongly decreases probability. Globally, ~900 H5N1 human cases have occurred since 2003, with the US only recently surpassing the threshold of dozens per year. A jump to 10,000 US cases in a few weeks would be unprecedented."
                },
                {
                    "factor": "Case Definition and Resolution Criteria",
                    "effect": "Decreases probability. Only confirmed and probable cases count. Asymptomatic or undetected cases, even if present, will not be included unless specifically counted and published by the CDC prior to Jan 1, 2026."
                },
                {
                    "factor": "Surveillance Gaps and Underascertainment",
                    "effect": "Ambiguous effect. While underascertainment means true infections may be higher, for the purpose of this question, only publicly reported confirmed/probable cases matter, so the number will likely be *lower* than true incidence."
                }
            ],
            "no_scenario": "Despite high levels of H5N1 in US poultry, cattle, and sporadic spillover to humans, the number of confirmed/probable human cases reported by CDC remains in the low hundreds at most due to limited transmission, lack of efficient human-to-human spread, and CDC resource constraints. No sudden mutation or reporting surge occurs before January 1, 2026.",
            "yes_scenario": "A dramatic, unprecedented shift occurs: H5N1 mutates into a form capable of efficient human-to-human transmission in late 2025, causing widespread symptomatic outbreaks. The CDC is able to rapidly detect, confirm, and publicly report thousands of new human cases before the end of 2025, such that the cumulative count exceeds 10,000.",
            "final_reasoning": "The status quo, base rates, and surveillance realities overwhelmingly point toward a 'No' outcome. Even amid the largest animal outbreaks on record, US human H5N1 case counts have not approached 1,000, let alone 10,000, in any year. The CDC's reporting system is currently impaired by the federal shutdown, further reducing the likelihood of large numbers of cases being confirmed and published in the next two months. The mutation risk highlighted in the literature is real but has not materialized in the US, and even if it did, it is unlikely that 10,000 confirmed/probable cases could be reported before January 1, 2026, given the current pace and reporting delays. The only plausible 'Yes' scenario requires both a sudden, massive epidemiological shift and a rapid, large-scale surveillance and reporting response, both of which are unprecedented and unsupported by current data. Therefore, the probability that CDC reports 10,000 or more H5 human cases before Jan 1, 2026, is extremely low.",
            "final_probability": 1
        }
    },
    "deliberation_probability": [
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1
    ],
    "deliberation_mean_probability": 1.0,
    "deliberation_sd": 0.0,
    "deliberation_probability_result": 1
}